These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 19358279)
1. The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells. Sahni A; Arévalo MT; Sahni SK; Simpson-Haidaris PJ Int J Cancer; 2009 Aug; 125(3):577-84. PubMed ID: 19358279 [TBL] [Abstract][Full Text] [Related]
2. Integrin α2β1 mediates tyrosine phosphorylation of vascular endothelial cadherin induced by invasive breast cancer cells. Haidari M; Zhang W; Caivano A; Chen Z; Ganjehei L; Mortazavi A; Stroud C; Woodside DG; Willerson JT; Dixon RA J Biol Chem; 2012 Sep; 287(39):32981-92. PubMed ID: 22833667 [TBL] [Abstract][Full Text] [Related]
3. The expression of VE-cadherin in breast cancer cells modulates cell dynamics as a function of tumor differentiation and promotes tumor-endothelial cell interactions. Rezaei M; Cao J; Friedrich K; Kemper B; Brendel O; Grosser M; Adrian M; Baretton G; Breier G; Schnittler HJ Histochem Cell Biol; 2018 Jan; 149(1):15-30. PubMed ID: 29143117 [TBL] [Abstract][Full Text] [Related]
4. Disruption of endothelial adherens junction by invasive breast cancer cells is mediated by reactive oxygen species and is attenuated by AHCC. Haidari M; Zhang W; Wakame K Life Sci; 2013 Dec; 93(25-26):994-1003. PubMed ID: 24211779 [TBL] [Abstract][Full Text] [Related]
6. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Schulz B; Pruessmeyer J; Maretzky T; Ludwig A; Blobel CP; Saftig P; Reiss K Circ Res; 2008 May; 102(10):1192-201. PubMed ID: 18420943 [TBL] [Abstract][Full Text] [Related]
7. The Influence of VE-Cadherin on Adhesion and Incorporation of Breast Cancer Cells into Vascular Endothelium. Brock T; Boudriot E; Klawitter A; Großer M; Nguyen TTP; Giebe S; Klapproth E; Temme A; El-Armouche A; Breier G Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205118 [TBL] [Abstract][Full Text] [Related]
8. VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers. Bartolomé RA; Torres S; Isern de Val S; Escudero-Paniagua B; Calviño E; Teixidó J; Casal JI Oncotarget; 2017 Jan; 8(1):215-227. PubMed ID: 27966446 [TBL] [Abstract][Full Text] [Related]
9. VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability. Guo M; Breslin JW; Wu MH; Gottardi CJ; Yuan SY Am J Physiol Cell Physiol; 2008 Apr; 294(4):C977-84. PubMed ID: 18287330 [TBL] [Abstract][Full Text] [Related]
10. Chlamydia pneumoniae infection promotes monocyte transendothelial migration by increasing vascular endothelial cell permeability via the tyrosine phosphorylation of VE-cadherin. Liu J; Miao G; Wang B; Zheng N; Ma L; Chen X; Wang G; Zhao X; Zhang L; Zhang L Biochem Biophys Res Commun; 2018 Mar; 497(2):742-748. PubMed ID: 29462613 [TBL] [Abstract][Full Text] [Related]
11. Transference of recombinant VE-cadherin cytoplasmic domain alters endothelial junctional integrity and porcine microvascular permeability. Guo M; Wu MH; Granger HJ; Yuan SY J Physiol; 2004 Jan; 554(Pt 1):78-88. PubMed ID: 14678493 [TBL] [Abstract][Full Text] [Related]
12. The presence of alpha-catenin in the VE-cadherin complex is required for efficient transendothelial migration of leukocytes. van Buul JD; van Alphen FP; Hordijk PL Int J Biol Sci; 2009 Nov; 5(7):695-705. PubMed ID: 19918298 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation. Hatanaka K; Simons M; Murakami M Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H162-72. PubMed ID: 21037229 [TBL] [Abstract][Full Text] [Related]
14. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions. Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220 [TBL] [Abstract][Full Text] [Related]
15. Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation. Friedl J; Turner E; Alexander HR Int J Oncol; 2003 Sep; 23(3):611-6. PubMed ID: 12888895 [TBL] [Abstract][Full Text] [Related]
16. Endothelial cadherins in cancer. Breier G; Grosser M; Rezaei M Cell Tissue Res; 2014 Mar; 355(3):523-7. PubMed ID: 24619142 [TBL] [Abstract][Full Text] [Related]
17. Ionizing radiation increases the endothelial permeability and the transendothelial migration of tumor cells through ADAM10-activation and subsequent degradation of VE-cadherin. Kouam PN; Rezniczek GA; Adamietz IA; Bühler H BMC Cancer; 2019 Oct; 19(1):958. PubMed ID: 31619190 [TBL] [Abstract][Full Text] [Related]
18. Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: localization of the fibrin-binding site within the third extracellular VE-cadherin domain. Yakovlev S; Medved L Biochemistry; 2009 Jun; 48(23):5171-9. PubMed ID: 19413351 [TBL] [Abstract][Full Text] [Related]
19. Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier. Minagar A; Long A; Ma T; Jackson TH; Kelley RE; Ostanin DV; Sasaki M; Warren AC; Jawahar A; Cappell B; Alexander JS Endothelium; 2003; 10(6):299-307. PubMed ID: 14741845 [TBL] [Abstract][Full Text] [Related]
20. Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells. Endo Y; Deonauth K; Prahalad P; Hoxter B; Zhu Y; Byers SW PLoS One; 2008 Jul; 3(7):e2714. PubMed ID: 18628953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]